Welcome to Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.!Stock code: 603456
Home|中文版

Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.

北京pk在线计划-北京pk计划网站-北京pk赛车高频彩Generalmanager officer: +86-576-88827580

E-mail: jiuzhou@jiuzhoupharma.com

Investment & Sevuritise Dept: +86-576-88706789

E-mail: 603456@jiuzhoupharma.com

Sale Dept: +86-576-88827561

E-mail: sale@jiuzhoupharma.com

北京pk在线计划-北京pk计划网站-北京pk赛车高频彩Human resource Dept: +86-576-88827582

E-mail: hr@jiuzhoupharma.com

Fax: +86-576-88827559

北京pk在线计划-北京pk计划网站-北京pk赛车高频彩Add: 99 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province, PRC Postal (318000)

About us

北京pk在线计划-北京pk计划网站-北京pk赛车高频彩Current location: Home > About us

     

Zhejiang Jiuzhou Pharmaceutical Co., Ltd, (Abbr. Jiuzhou Pharma, Stock code 603456), was formed in 1998. The company evolved out of the Dongshan Chemical Factory which dates back to 1973.

Jiuzhou Pharma is committed to the research & development, production, and sale of active pharmaceutical ingredients (APIs). In addition, the company offers one-stop CDMO services for global pharmaceutical giants in Asia, Europe and North America. Jiuzhou Pharma is the top API manufacturer and supplier of Carbamazepine, Oxcarbazepine, Ketoprofen and Gliclazide worldwide.  The company has been honored with a number of industry and government accolades including, “Top 100 in the Chinese Pharmaceutical Industry ”, “China's Leading Exporter of APIs”, “National High-Tech Enterprise”, “National Technology Innovation Demonstration Enterprises”,“Zhejiang ‘Sanming’ Cultivation Pilot Enterprises”,“Zhejiang Innovative Leading Enterprises”, etc.. “Jiuzhou” is widely regarded as the most well-known export brand to come out of Zhejiang.

Jiuzhou’s API is highly competitive internationally. The company has a sterling track record with regulatory authorities including the FDA and EDQM. Jiuzhou has diverse API experience and a robust pipeline which includes central nervous system drugs, non-steroidal drugs, anti-infection drugs, hypoglycemic drugs, tumor treatment drugs, anti-depressant drugs, Parkinson treatment drugs, HCV drugs, diabetes drugs and respiratory anti-infection drugs. The company’s experience across many areas of pharmaceutical manufacturing and history of excellence makes for a bright future.

At Jiuzhou, we are committed to excellence. The manufacturing and research systems and processes we have in place are mature and reflect this commitment. The company has three production sites located in Taizhou, Zhejiang and Yancheng, Jiangsu. Jiuzhou’s R&D division includes innovation platforms like our National Certified Enterprise Technology Center, National Post-Doctoral Scientific Research Workstation, Provincial Academician Expert Workstation and Research Institute of Key Enterprises in Zhejiang. There are R&D centers in Hangzhou, Taizhou and the United States. We employ a high-level, professional, and international team. Among them, one team member enjoys special government allowances of the State Council, and eight are high-level, national, and provincial experts. These world class teams have been honored as “Zhejiang Technological Innovation Teams in Key Enterprises” and “Zhejiang Leading Innovation and Entrepreneurial Teams”.

Jiuzhou R&D is leading in the field of core chemical technology, research and development and innovation in the Pharmaceutical industry. It has undertaken more than 30 national and provincial research projects. To this date, the company has 139 granted invention patents and 2 utility model patents. Jiuzhou has made a long standing commitment to the research and development of Green Chemical Pharmaceutical technology. Globally the company is a leading innovator in areas such as asymmetric chiral synthesis, fluorine chemistry, 北京pk在线计划-北京pk计划网站-北京pk赛车高频彩enzyme catalysis and Continuous Micro-reactor technology.

 “Jiuzhou, in sync with the world". Adhering to the mission of "Caring for Life, Maintaining the Health". The company remains committed to maintaining the steady growth of its traditional products while at the same time it will vigorously develop the new drug CDMO business. Jiuzhou will continue to grow and innovate, entering new areas of business covering generic drug service北京pk在线计划-北京pk计划网站-北京pk赛车高频彩 “API + Preparation”. Jiuzhou aims to be a first-class, internationally influential, “patient oriented pharmaceutical company", while making greater contributions to human health.

Copyright(C)2017, Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by    Copyright Notice
百万文字论坛综合资料转载-百万文字论坛转载各坛-03024百万文字论坛转载 澳门49图库开奖结果-49tkcom澳彩开奖结果-49图库澳门彩 808彩票网论坛-808彩票网808cpcom-七星彩808彩808cpcom-南国彩票808cpcom 银河棋牌网站-8266cc银河棋牌-6663121永发棋牌 8266cc银河棋牌-打鱼棋牌游戏平台-能赚钱棋牌游戏平台 澳门凤凰天机网876161con-凤凰天机六肖-319222凤凰天机-凤凰天机247878-凤凰天机网资料大全 626969cc澳门资料大全-澳门123696con393444-2021澳门合彩开彩结果 香港马料免费大全559958-9944cc天下香港挂牌-83055con香港挂牌